Estetrol Approvals Mark 'Turning Point' For Mithra
Also Plans Further Launches Of Myring Generic Rival To NuvaRing
Recent Canadian, European and US endorsements of Mithra’s estetrol-based Estelle novel oral contraceptive mark a “turning point” for the Belgian firm, which has also seen success with its Myring generic rival to NuvaRing for which it expects to see further launches this year.
